What Louisiana v. FDA Could Mean for Telehealth Abortion

A Louisiana lawsuit, Louisiana v. FDA, is before the Fifth Circuit Court of Appeals and asks the court to undo federal policies that allow clinicians to prescribe the abortion pill mifepristone via telehealth and have it mailed to patients. That would reimpose in-person dispensing requirements and could block mail delivery, changing how medication abortion is provided across the country.

How telehealth abortion currently works

A clinic's workflow, in one example

• Patients uncertain about gestational age can come to clinic for an ultrasound, then use the clinic's telehealth suite for the consult.
• The clinician discusses the two drugs: mifepristone (which halts pregnancy progression) and misoprostol (taken later to complete the process).

Mifepristone is FDA-approved for use before 11 weeks of pregnancy. Telehealth models vary by clinic and state law: some states restrict telehealth provision of mifepristone, while others allow out-of-state clinicians to prescribe and mail medication to residents. In Arizona, for example, state-level restrictions previously prevented telehealth access until a court cleared the way for one clinic to begin services earlier this year.

Telehealth medication abortion has grown rapidly. Data cited in reporting shows roughly 91,000 abortions were provided last year via telehealth prescriptions mailed into states with bans, including more than 9,300 mailed into Louisiana. If the appeals court grants Louisiana's request and restores stricter in-person requirements, many of those telehealth pathways would be cut off.

What's at stake legally and practically

The case centers on whether the FDA's post-pandemic policy allowing remote prescription and mailing of mifepristone was lawful and safe. If the court accepts Louisiana's claim, the immediate legal effect could be to limit or halt nationwide telehealth prescribing and mailing of the drug. Practically, patients who rely on telehealth to access medication abortion would face travel, clinic wait times, and the logistical hurdles of in-person dispensing.

Oral arguments took place at the Fifth Circuit in New Orleans. Clinicians who have built telehealth services say they're prepared to continue care if allowed but are braced for the possibility that access could be curtailed again depending on the court's ruling.

If you rely on or provide telehealth medication abortion, follow state and clinic communications closely. A court ruling for Louisiana could reinstate in-person dispensing rules and reduce the availability of mailed medication, especially in states that already restrict abortion care.